Disclosures for "Samelisant (SUVN-G3031) - Topline Results from the Phase-2 Proof-of-Concept Double-blind, Placebo-controlled Study in Patients with Narcolepsy"
-
Dr. Nirogi has nothing to disclose.
-
Pradeep Jayarajan has nothing to disclose.
-
Mr. BENADE has nothing to disclose.
-
Vinod Goyal has nothing to disclose.
-
Anil Shinde has nothing to disclose.
-
Jyothsna Ravula has nothing to disclose.
-
Satish Jeta has nothing to disclose.
-